As Cummins Com (CMI) Stock Declined, Holder First Merchants Has Increased Holding; As Biogen (BIIB) Market Valuation Declined, Global Endowment Management LP Trimmed by $706,000 Its Stake

Cummins Inc. (NYSE:CMI) Logo

Global Endowment Management Lp decreased its stake in Biogen Inc (BIIB) by 9.06% based on its latest 2018Q3 regulatory filing with the SEC. Global Endowment Management Lp sold 2,000 shares as the company’s stock declined 6.12% with the market. The institutional investor held 20,080 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $7.10M, down from 22,080 at the end of the previous reported quarter. Global Endowment Management Lp who had been investing in Biogen Inc for a number of months, seems to be less bullish one the $66.51 billion market cap company. The stock increased 1.06% or $3.47 during the last trading session, reaching $330.1. About 461,829 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 0.04% since January 10, 2018 and is downtrending. It has underperformed by 0.04% the S&P500. Some Historical BIIB News: 24/04/2018 – Biogen 1Q Multiple Sclerosis Rev $2.1 Billion; 24/04/2018 – Biogen Idec 1Q EPS $5.54; 15/05/2018 – Bridgewater Adds Biogen, Exits Costco, Buys More Newfield: 13F; 10/04/2018 – AveXis sells on Novartis approach; 24/04/2018 – Biogen Idec 1Q Net $1.2B; 20/04/2018 – Biogen boosts investment in neurology with $1 bln Ionis deal; 20/04/2018 – $BIIB $IONS Interesting slide on antisense and gene therapy being “Complementary”, “Combination / sequential”. Will see if Biogen answer any question re $AVXS; 05/04/2018 – AbbVie in deal with Biogen to delay Humira biosimilar U.S. launch to 2023; 20/04/2018 – BIOGEN – IN COLLABORATION BIOGEN WILL BE RESPONSIBLE FOR AND PAY FOR NON-CLINICAL STUDIES, CLINICAL DEVELOPMENT, MANUFACTURING, AND COMMERCIALIZATION; 05/04/2018 – BIOGEN INC – COMPANIES HAVE AGREED TO DISMISS ALL PENDING PATENT LITIGATION

First Merchants Corp increased its stake in Cummins Inc Com (CMI) by 9.46% based on its latest 2018Q3 regulatory filing with the SEC. First Merchants Corp bought 2,828 shares as the company’s stock declined 4.30% with the market. The institutional investor held 32,724 shares of the industrial machinery and components company at the end of 2018Q3, valued at $4.78 million, up from 29,896 at the end of the previous reported quarter. First Merchants Corp who had been investing in Cummins Inc Com for a number of months, seems to be bullish on the $22.29B market cap company. The stock increased 1.30% or $1.79 during the last trading session, reaching $139.26. About 641,221 shares traded. Cummins Inc. (NYSE:CMI) has declined 19.50% since January 10, 2018 and is downtrending. It has underperformed by 19.50% the S&P500. Some Historical CMI News: 24/05/2018 – CUMMINS INDIA 4Q REV. 12.1B RUPEES; 27/04/2018 – FOCUS-U.S. sanctions risk hurting Russian van maker GAZ; 18/04/2018 – Cummins at Wells Fargo Securities Industrials Conference May 9; 24/05/2018 – CUMMINS INDIA FY DIV/SHR 10 RUPEES; 24/05/2018 – CUMMINS INDIA LTD CUMM.NS – MARCH QTR INCOME FROM OPS 12.06 BLN RUPEES VS 12.39 BLN RUPEES YR AGO; 22/03/2018 – Cricket-De Villiers wicket was catalyst for turnaround – Cummins; 24/05/2018 – CUMMINS INDIA LTD CUMM.NS – CO IS POSITIVE ON MEDIUM TO LONG TERM OUTLOOK FOR DOMESTIC SALES AS UNDERLYING DEMAND CONDITIONS REMAIN POSITIVE; 14/05/2018 – CUMMINS & JAC MOTORS FORM JOINT VENTURE PARTNERSHIP; 24/05/2018 – CUMMINS INDIA 4Q TOTAL COSTS 10.9B RUPEES; 12/03/2018 – Abaco Systems Names Christopher G. Cummins Chief Operating Officer

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on January, 29 before the open. They expect $6.72 earnings per share, up 27.76% or $1.46 from last year’s $5.26 per share. BIIB’s profit will be $1.35B for 12.28 P/E if the $6.72 EPS becomes a reality. After $7.40 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -9.19% negative EPS growth.

Investors sentiment decreased to 1.01 in 2018 Q3. Its down 0.01, from 1.02 in 2018Q2. It fall, as 45 investors sold BIIB shares while 334 reduced holdings. 138 funds opened positions while 243 raised stakes. 167.21 million shares or 1.69% less from 170.10 million shares in 2018Q2 were reported. Riverhead Cap Mgmt Ltd Limited Liability Company holds 69,901 shares. Tdam Usa Inc stated it has 699 shares or 0.01% of all its holdings. 105,484 were accumulated by Seizert Cap Prtn Limited Liability. New Vernon Capital Holdings Ii Ltd Liability Co invested in 582 shares or 0.21% of the stock. Sumitomo Life Ins reported 10,510 shares. Moreover, First Quadrant Lp Ca has 0.85% invested in Biogen Inc. (NASDAQ:BIIB). Kepos Lp reported 0.34% stake. Martingale Asset LP reported 11,262 shares. First Personal Service, a North Carolina-based fund reported 141 shares. Amer Financial Gru has 7,000 shares for 0.24% of their portfolio. Moreover, Nuveen Asset Mgmt Limited Liability Company has 0.14% invested in Biogen Inc. (NASDAQ:BIIB). Evergreen Cap Limited Liability Corporation reported 1,125 shares or 0.04% of all its holdings. Lowe Brockenbrough & Com Inc invested in 1,003 shares or 0.05% of the stock. Bradley Foster Sargent Ct, Connecticut-based fund reported 4,130 shares. Putnam Fl Inv Management accumulated 0.04% or 1,162 shares.

Global Endowment Management Lp, which manages about $5.46 billion and $754.45 million US Long portfolio, upped its stake in Facebook Inc (NASDAQ:FB) by 20,000 shares to 115,000 shares, valued at $18.91 million in 2018Q3, according to the filing. It also increased its holding in Zillow Group Inc by 7,300 shares in the quarter, for a total of 414,642 shares, and has risen its stake in Mckesson Corp (NYSE:MCK).

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Nasdaq.com which released: “Surprising Analyst 12-Month Target For QUS – Nasdaq” on December 18, 2018, also Nasdaq.com with their article: “Alkermes and Biogen Announce Submission of a New Drug Application to US Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis – Nasdaq” published on December 17, 2018, Seekingalpha.com published: “Quebec to cover Biogen’s SMA med Spinraza – Seeking Alpha” on December 20, 2018. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Streetinsider.com and their article: “Biogen (BIIB) Applauds Quebec Decision to Cover SPINRAZA for broad population of SMA Patients – StreetInsider.com” published on December 20, 2018 as well as Seekingalpha.com‘s news article titled: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” with publication date: January 10, 2019.

Among 35 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 27 have Buy rating, 0 Sell and 8 Hold. Therefore 77% are positive. Biogen Idec Inc. had 147 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, April 24 by Jefferies. Mizuho upgraded the stock to “Buy” rating in Tuesday, October 17 report. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, April 25. The firm has “Conviction Buy” rating by Goldman Sachs given on Wednesday, August 16. On Wednesday, October 25 the stock rating was upgraded by BMO Capital Markets to “Outperform”. As per Monday, November 27, the company rating was maintained by BMO Capital Markets. The company was maintained on Tuesday, August 2 by Raymond James. On Thursday, May 31 the stock rating was upgraded by Canaccord Genuity to “Buy”. As per Tuesday, September 1, the company rating was initiated by Raymond James. The firm has “Buy” rating by Stifel Nicolaus given on Monday, October 23.

Since September 26, 2018, it had 0 buys, and 1 insider sale for $350,000 activity.

First Merchants Corp, which manages about $610.00M US Long portfolio, decreased its stake in Lam Research Corp Com (NASDAQ:LRCX) by 4,752 shares to 4,266 shares, valued at $647,000 in 2018Q3, according to the filing. It also reduced its holding in Kimberly Clark Corp Com (NYSE:KMB) by 7,707 shares in the quarter, leaving it with 18,943 shares, and cut its stake in S&P Mid (IJJ).

Among 33 analysts covering Cummins (NYSE:CMI), 11 have Buy rating, 1 Sell and 21 Hold. Therefore 33% are positive. Cummins had 133 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Underweight” rating given on Friday, September 25 by Barclays Capital. The stock of Cummins Inc. (NYSE:CMI) has “Hold” rating given on Wednesday, October 28 by Deutsche Bank. The firm has “Overweight” rating by Piper Jaffray given on Thursday, April 21. The rating was upgraded by Barclays Capital to “Equal Weight” on Monday, January 9. The rating was maintained by Stifel Nicolaus on Wednesday, October 18 with “Hold”. The company was downgraded on Monday, January 25 by Citigroup. The stock has “Buy” rating by Standpoint Research on Monday, June 18. Deutsche Bank maintained the stock with “Sell” rating in Wednesday, August 2 report. As per Friday, January 19, the company rating was upgraded by Bank of America. The stock of Cummins Inc. (NYSE:CMI) earned “Buy” rating by Buckingham Research on Wednesday, November 1.

More recent Cummins Inc. (NYSE:CMI) news were published by: Seekingalpha.com which released: “Cummins: Keep On Trucking With This Undervalued Stock – Seeking Alpha” on January 08, 2019. Also Benzinga.com published the news titled: “Clean Energy Fuels Corp. (NASDAQ:CLNE), Cummins Inc. (NYSE:CMI) – Today’s Pickup: Port Operator Secures $1 Per Gallon Natural Gas Deal For New Trucks – Benzinga” on January 08, 2019. Fool.com‘s news article titled: “What’s in Store for Caterpillar in 2019? – Motley Fool” with publication date: December 22, 2018 was also an interesting one.

Since October 2, 2018, it had 0 insider buys, and 10 insider sales for $9.61 million activity. Smith Mark Andrew sold 501 shares worth $76,788. $87,974 worth of Cummins Inc. (NYSE:CMI) was sold by ChangDiaz Franklin R on Thursday, November 15. Satterthwaite Tony had sold 830 shares worth $117,533 on Monday, November 5. Another trade for 5,307 shares valued at $796,050 was sold by Cook Jill E. 4,503 shares were sold by Ward Pat, worth $670,618. HERMAN ALEXIS M had sold 775 shares worth $111,321 on Monday, November 5.

Cummins Inc. (NYSE:CMI) Institutional Positions Chart